Patrick Cabri

Patrick Cabri has extensive experience in the medical field, currently serving as Global Medical Director for Decapeptyl at Ipsen since May 2012, overseeing medical activities within the Global urology-oncology franchise. Prior to this, Patrick held the position of Medical Director for Benelux at Ipsen from 2008 to 2012, managing a team within the medical, clinical, and safety departments. Patrick's career includes roles such as MD in IVF fertility from 2005 to 2008 and Vice President of Medical Affairs for Europe at Genzyme Europe BV from 1998 to 2005, where responsibilities included overseeing medical, clinical, and pharmacovigilance activities. Earlier positions include Business Head for Renal and Transplantation at Roche and Global Medical Director for Carvedilol and Bezafibrate at Boehringer Mannheim, where responsibilities included leading significant clinical studies. Patrick began their career as a Medical Adviser at Fournier Pharma. Patrick holds an MD in Medicine from Ghent University.